Search

Deborah Crouch

Examiner (ID: 4504, Phone: (571)272-0727 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1804, 1819, 2899, 1632, 3725
Total Applications
1439
Issued Applications
694
Pending Applications
237
Abandoned Applications
511

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8227900 [patent_doc_number] => 20120142110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Method of Genetically Altering and Producing Allergy Free Cats' [patent_app_type] => utility [patent_app_number] => 13/168664 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23865 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168664 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/168664
Method of Genetically Altering and Producing Allergy Free Cats Jun 23, 2011 Abandoned
Array ( [id] => 7662732 [patent_doc_number] => 20110312001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/161149 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28762 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312001.pdf [firstpage_image] =>[orig_patent_app_number] => 13161149 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/161149
COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE Jun 14, 2011 Abandoned
Array ( [id] => 7656408 [patent_doc_number] => 20110305677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'HUMAN EMBRYONIC STEM CELL CULTURES, AND COMPOSITIONS AND METHODS FOR GROWING SAME' [patent_app_type] => utility [patent_app_number] => 13/153146 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15040 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305677.pdf [firstpage_image] =>[orig_patent_app_number] => 13153146 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/153146
HUMAN EMBRYONIC STEM CELL CULTURES, AND COMPOSITIONS AND METHODS FOR GROWING SAME Jun 2, 2011 Abandoned
Array ( [id] => 8065163 [patent_doc_number] => 20110244450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'PRIMATE TOTIPOTENT AND PLURIPOTENT STEM CELLS PRODUCED BY SOMATIC CELL NUCLEAR TRANSFER' [patent_app_type] => utility [patent_app_number] => 13/149543 [patent_app_country] => US [patent_app_date] => 2011-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 32259 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20110244450.pdf [firstpage_image] =>[orig_patent_app_number] => 13149543 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/149543
PRIMATE TOTIPOTENT AND PLURIPOTENT STEM CELLS PRODUCED BY SOMATIC CELL NUCLEAR TRANSFER May 30, 2011 Abandoned
Array ( [id] => 7665296 [patent_doc_number] => 20110314565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Method for Isolating Cell-Type Specific mRNAS' [patent_app_type] => utility [patent_app_number] => 13/104316 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33256 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13104316 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/104316
Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tag May 9, 2011 Issued
Array ( [id] => 10522890 [patent_doc_number] => 09249390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-02 [patent_title] => 'Method for producing polarized retinal progenitor cells from pluripotent stem cells and their differentiation into retinal pigment epithelium cells' [patent_app_type] => utility [patent_app_number] => 13/096598 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8455 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096598 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/096598
Method for producing polarized retinal progenitor cells from pluripotent stem cells and their differentiation into retinal pigment epithelium cells Apr 27, 2011 Issued
Array ( [id] => 8130983 [patent_doc_number] => 20120090039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'Immunocompromised Ungulates' [patent_app_type] => utility [patent_app_number] => 13/092242 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32991 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20120090039.pdf [firstpage_image] =>[orig_patent_app_number] => 13092242 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/092242
Immunocompromised Ungulates Apr 21, 2011 Abandoned
Array ( [id] => 6111503 [patent_doc_number] => 20110189767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS OF PREPARING FEEDER CELLS-FREE, XENO-FREE HUMAN EMBRYONIC STEM CELLS AND STEM CELL CULTURES PREPARED USING SAME' [patent_app_type] => utility [patent_app_number] => 13/083630 [patent_app_country] => US [patent_app_date] => 2011-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15424 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189767.pdf [firstpage_image] =>[orig_patent_app_number] => 13083630 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/083630
Tissue culture medium comprising transforming growth factor beta 1 and basic fibroblast growth factor Apr 10, 2011 Issued
Array ( [id] => 6143182 [patent_doc_number] => 20110129867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Compound Screening Using Chondrocytes' [patent_app_type] => utility [patent_app_number] => 13/021497 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129867.pdf [firstpage_image] =>[orig_patent_app_number] => 13021497 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/021497
Compound screening using chondrocytes derived from primate pluripotent stem cells Feb 3, 2011 Issued
Array ( [id] => 8477229 [patent_doc_number] => 20120276636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'METHOD FOR IMPROVING INDUCED PLURIPOTENT STEM CELL GENERATION EFFICIENCY' [patent_app_type] => utility [patent_app_number] => 13/497044 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16791 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497044 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/497044
Myc variants improve induced pluripotent stem cell generation efficiency Jan 20, 2011 Issued
Array ( [id] => 9440696 [patent_doc_number] => 08709806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'EpCAM as a reprogramming factor for non-pluripotent cells' [patent_app_type] => utility [patent_app_number] => 12/930154 [patent_app_country] => US [patent_app_date] => 2010-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 14581 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12930154 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/930154
EpCAM as a reprogramming factor for non-pluripotent cells Dec 27, 2010 Issued
Array ( [id] => 8479503 [patent_doc_number] => 20120278910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'Transgenic Pig in which HO-1 and TNFR1-Fc are Simultaneously Expressed, and Method for Producing Same' [patent_app_type] => utility [patent_app_number] => 13/520056 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9759 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520056 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/520056
Transgenic pig in which HO-1 and TNFR1-Fc are simultaneously expressed, and method for producing same Dec 20, 2010 Issued
Array ( [id] => 6079949 [patent_doc_number] => 20110142803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'METHOD FOR TREATING INFLAMMATION ASSOCIATED WITH AMYLOID DEPOSITS AND BRAIN INFLAMMATION INVOLVING ACTIVATED MICROGLIA' [patent_app_type] => utility [patent_app_number] => 12/966786 [patent_app_country] => US [patent_app_date] => 2010-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10874 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142803.pdf [firstpage_image] =>[orig_patent_app_number] => 12966786 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/966786
Method and filamentous phage for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia Dec 12, 2010 Issued
Array ( [id] => 10587934 [patent_doc_number] => 09309537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Chimeric rat produced using rat embryonic stem cells in the presence of an ES cell differentiation suppressant' [patent_app_type] => utility [patent_app_number] => 13/513100 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17863 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513100 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/513100
Chimeric rat produced using rat embryonic stem cells in the presence of an ES cell differentiation suppressant Nov 29, 2010 Issued
Array ( [id] => 9344530 [patent_doc_number] => 08663675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction' [patent_app_type] => utility [patent_app_number] => 12/948918 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11724 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12948918 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/948918
Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction Nov 17, 2010 Issued
Array ( [id] => 6202332 [patent_doc_number] => 20110065118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/947605 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13735 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065118.pdf [firstpage_image] =>[orig_patent_app_number] => 12947605 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/947605
Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells Nov 15, 2010 Abandoned
Array ( [id] => 8347949 [patent_doc_number] => 20120208871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'USE OF TOLL-LIKE RECEPTOR AND AGONIST FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/500552 [patent_app_country] => US [patent_app_date] => 2010-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 8518 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500552 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/500552
Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist Oct 5, 2010 Issued
Array ( [id] => 8054065 [patent_doc_number] => 20120076761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 12/896396 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21793 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076761.pdf [firstpage_image] =>[orig_patent_app_number] => 12896396 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/896396
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease Sep 30, 2010 Abandoned
Array ( [id] => 6095470 [patent_doc_number] => 20110002996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'ACELLULAR TISSUE MATRICES MADE FROM ALPHA-1,3-GALACTOSE-DEFICIENT TISSUE' [patent_app_type] => utility [patent_app_number] => 12/883515 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10668 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002996.pdf [firstpage_image] =>[orig_patent_app_number] => 12883515 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/883515
Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue Sep 15, 2010 Issued
Array ( [id] => 6134392 [patent_doc_number] => 20110008294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'METHODS FOR TREATING CANCER WITH MVA' [patent_app_type] => utility [patent_app_number] => 12/872156 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13456 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008294.pdf [firstpage_image] =>[orig_patent_app_number] => 12872156 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/872156
Methods for treating cancer with a recombinant MVA expressing HER-2 Aug 30, 2010 Issued
Menu